Soluna Executes Equipment Supply Agreement with Cormint for 12 MW Kati 1 Deployment
Agreement is a blueprint for future deployments across pipeline ALBANY, N.Y.–(BUSINESS WIRE)–Soluna Holdings, Inc. (“Soluna” or the “Company”)... Read more.
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
Company to host investor webcast and conference call on February 12 at 7 a.m. PT / 10 a.m. ET Investor webcast will feature the clinical validation data and review... Read more.
Bristol Myers Squibb Introduces “Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
Cardiovascular and thromboembolic diseases are among the leading causes of death and disability, accounting for nearly 1 million deaths in the U.S. annually Clinician-focused... Read more.
Pentair Announces New Executive Leadership Roles to Accelerate Growth and Enhance Customer Focus
LONDON–(BUSINESS WIRE)–Pentair plc (NYSE: PNR), a leader in helping the world sustainably move, improve and enjoy water, today announced new strategic... Read more.
PJT Partners Inc. Reports Record Full Year and Fourth Quarter 2025 Results
Full Year Overview Record Revenues, Pretax Income and EPS Revenues of $1.71 billion, an increase of 15% from a year ago GAAP Pretax Income of $343 million and Adjusted... Read more.
Pentair Reports Strong Fourth Quarter and Full Year 2025 Results
Fourth quarter sales of $1,021 million, up 5 percent; full year 2025 sales of $4.2 billion, up 2 percent. Operating income in the fourth quarter increased 5 percent... Read more.
Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance
Focused Execution Drives Strong Full-Year 2025 EPS Performance Enters 2026 with Clear Strategic Priorities and Growing Late-Stage Pipeline Advanced 11 Key Pivotal... Read more.
Rithm Capital Corp. Announces Fourth Quarter and Full Year 2025 Results
NEW YORK–(BUSINESS WIRE)–Rithm Capital Corp. (NYSE: RITM; “Rithm Capital,” “Rithm” or the “Company”) today reported the following information... Read more.
Capri Holdings Limited Announces Third Quarter Fiscal 2026 Results
Revenue and Earnings Per Share Exceed Expectations Reduced Net Debt to $80M at Quarter End LONDON–(BUSINESS WIRE)–Capri Holdings Limited (NYSE:CPRI),... Read more.
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline
Reports Strength in Oncology and Animal Health, Plus Increasing Contributions From WINREVAIR and CAPVAXIVE Fourth-Quarter Worldwide Sales Were $16.4 Billion (5%... Read more.